Literature DB >> 17116189

Divergent trends in the incidence of end-stage renal disease due to Type 1 and Type 2 diabetes in Europe, Canada and Australia during 1998-2002.

J H Stewart, M R E McCredie, S M Williams.   

Abstract

AIMS: To describe the variation in geographical distribution of end-stage renal disease (ESRD) due to Type 1 and Type 2 diabetes, and to calculate recent trends in incidence in predominantly white populations.
METHODS: Estimation of age- and sex-standardized incidence of ESRD by type of diabetes, and temporal trends, in population-based data for persons aged 30-44, 45-54 or 55-64 years newly treated for ESRD during 1998-2002 in eight countries or regions of Europe, and Non-Indigenous Canadians and Australians.
RESULTS: The incidence of ESRD due to Type 1 diabetes at age 30-44 years correlated with published rates of childhood-onset insulin dependent diabetes mellitus (P = 0.0025). ESRD due to Type 2 diabetes was uncommon before 45 years of age; in older persons, the highest rates (in Canada and Austria) were five times the lowest rates (in Norway and the Basque region). Rates of ESRD due to Type 1 diabetes fell, per year, by 6.4%[95% confidence interval (CI): 2.1-10.6%) in persons aged 30-44 years, and by 7.7% (95% CI: 2.4-12.7%] in those aged 45-54 years. In contrast, rates of ESRD due to Type 2 diabetes increased annually by 16% (95% CI: 5-28%) in the 30-44-year age group, 11% (95% CI: 6-16%) at 45-54 years, and 9% (95% CI: 5-14%) at 55-64 years.
CONCLUSIONS: Modern prevention has reduced progression of nephropathy to ESRD due to Type 1 diabetes, but the continuing rise of ESRD due to Type 2 diabetes represents a failure of current disease control measures that has serious public health implications.

Entities:  

Mesh:

Year:  2006        PMID: 17116189     DOI: 10.1111/j.1464-5491.2006.01986.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  9 in total

Review 1.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 2.  Global trends in diabetes complications: a review of current evidence.

Authors:  Jessica L Harding; Meda E Pavkov; Dianna J Magliano; Jonathan E Shaw; Edward W Gregg
Journal:  Diabetologia       Date:  2018-08-31       Impact factor: 10.122

3.  Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980-2007.

Authors:  Mikko Haapio; Jaakko Helve; Per-Henrik Groop; Carola Grönhagen-Riska; Patrik Finne
Journal:  Diabetes Care       Date:  2010-04-30       Impact factor: 19.112

Review 4.  Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.

Authors:  Giorgina B Piccoli; Giorgio Grassi; Gianfranca Cabiddu; Marta Nazha; Simona Roggero; Irene Capizzi; Agostino De Pascale; Adriano M Priola; Cristina Di Vico; Stefania Maxia; Valentina Loi; Anna M Asunis; Antonello Pani; Andrea Veltri
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 5.  Diabetes and chronic kidney disease: lessons from the Pima Indians.

Authors:  Kevin V Lemley
Journal:  Pediatr Nephrol       Date:  2008-03-05       Impact factor: 3.714

6.  Growth-differentiation factor 15 predicts worsening of albuminuria in patients with type 2 diabetes.

Authors:  Merel E Hellemons; Magdalena Mazagova; Ron T Gansevoort; Robert H Henning; Dick de Zeeuw; Stephan J L Bakker; Hiddo J Lambers-Heerspink; Leo E Deelman
Journal:  Diabetes Care       Date:  2012-07-18       Impact factor: 19.112

7.  Five-year incidence of chronic kidney disease (stage 3-5) and associated risk factors in a Spanish cohort: the MADIABETES Study.

Authors:  Miguel A Salinero-Fort; Francisco J San Andrés-Rebollo; Carmen de Burgos-Lunar; Paloma Gómez-Campelo; Rosa M Chico-Moraleja; Ana López de Andrés; Rodrigo Jiménez-García
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

8.  Low-Protein Diets in Diabetic Chronic Kidney Disease (CKD) Patients: Are They Feasible and Worth the Effort?

Authors:  Giorgina B Piccoli; Federica Ventrella; Irene Capizzi; Federica N Vigotti; Elena Mongilardi; Giorgio Grassi; Valentina Loi; Gianfranca Cabiddu; Paolo Avagnina; Elisabetta Versino
Journal:  Nutrients       Date:  2016-10-21       Impact factor: 5.717

9.  Cumulative Kidney Complication Risk by 50 Years of Type 1 Diabetes: The Effects of Sex, Age, and Calendar Year at Onset.

Authors:  Tina Costacou; Trevor J Orchard
Journal:  Diabetes Care       Date:  2017-09-20       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.